Shares of tobacco firms fall after a Reuters report that popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast-track FDA scheme
Philip Morris International PM.N falls 6.3% to its lowest since early Jan
Turning Point Brands TPB.N slumps 20.5% to its lowest since May 2025 and Altria MO.N drops 2.3%
The U.S. health agency's scientists are hesitating to authorize pouches due to potential risks to new users, including children, sources told Reuters
Hold-ups seen as a setback for firms such as PM, which has pending applications for newer versions of its Zyn brand, and British American Tobacco BATS.L with its Velo label